Pharmaceuticals and Biotechnology Option and Evaluation Agreements Analysis Report 2025 with Directory of Deals Signed Since 2019 - Upfront, Royalty, Milestone Financials
DUBLIN--(BUSINESS WIRE)--The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" has been added to ResearchAndMarkets.com's offering.
This report contains a comprehensive listing of option and evaluation deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter option and evaluation deals. Fully revised and updated, the report provides details of option and evaluation deals from 2019 to 2025.
The report provides access to option and evaluation deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
The initial chapters of this report provide an orientation of option and evaluation dealmaking and business activities. Chapter 1 introduces the report, followed by Chapter 2 which offers an overview and analysis of the trends in option and evaluation deals, alongside discussing the merits of such deals. Chapter 3 details the structure of option and evaluation deals, while Chapter 4 reviews the leading deals since 2019, ordered by headline value. Chapter 5 lists the top 25 active dealmakers with available links to full records and contracts, and Chapter 6 provides an organized review of deals by company, therapy, technology, and industry type, offering insights into agreed terms.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
Understand deal trends since 2019
Browse option and evaluation deals
Benchmark analysis - identify market value of transactions
Financials terms
Directory of deals by company A-Z, therapy focus and technology type
Leading deals by value
Most active dealmakers
Identify assets and deal terms for each transaction
Access contract documents - insights into deal structures
Due diligence - assess suitability of your proposed deal terms for partner companies
Save hundreds of hours of research time
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in option and evaluation dealmaking
2.1. Introduction
2.2. Definition of option and evaluation deal
2.3. Trends in option and evaluation deals since 2019
2.3.1. Option and evaluation dealmaking by year, 2019-2025
2.3.2. Option and evaluation dealmaking by phase of development, 2019-2025
2.3.3. Option and evaluation dealmaking by industry sector, 2019-2025
2.3.4. Option and evaluation dealmaking by therapy area, 2019-2025
2.3.5. Option and evaluation dealmaking by technology type, 2019-2025
2.3.6. Option and evaluation dealmaking by most active company, 2019-2025
2.4. Reasons for entering into option and evaluation partnering deals
2.5. The future of option and evaluation deals
Chapter 3 - Overview of option and evaluation deal structure
3.1. Introduction
3.2. Option and evaluation agreement structure
Chapter 4 - Leading option and evaluation deals
4.1. Introduction
4.2. Top option and evaluation deals by value
Chapter 5 - Top 25 most active option and evaluation dealmakers
5.1. Introduction
5.2. Top 25 most active option and evaluation dealmakers
Chapter 6 - option and evaluation deals including contracts directory
6.1. Introduction
6.2. Option and evaluation deals with contracts 2019-2025
Deal directory
Deal directory - option and evaluation dealmaking by companies A-Z
Deal directory - option and evaluation dealmaking by therapy area
Deal directory - option and evaluation dealmaking by technology type
For more information about this report visit https://www.researchandmarkets.com/r/s92ukz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Western Union Appoints Ricardo Alair to Lead Operations Across the Philippines, Guam, Northern Mariana Islands and Palau
MANILA, Philippines--(BUSINESS WIRE)--Western Union today announced the appointment of Ricardo Alair as Director for the Philippines, Guam, Northern Mariana Islands and Palau. His appointment comes as the Company accelerates its growth strategy, expanding access to financial services for customers across the region. 'We are thrilled to welcome Ricardo to Western Union,' said Gregory Laurent, Western Union's Regional Vice President for Japan, Philippines, Australia, New Zealand & Pacific Islands. 'His extensive experience in financial services and telecoms, paired with a sharp understanding of the local market, makes him uniquely positioned to lead our operations in the Philippines and neighboring territories. Ricardo's leadership will play a key role in enhancing our customer experience and driving meaningful impact across the communities we serve.' With over 20 years of experience across financial services, telecommunications and business strategy, Alair brings a strong track record of innovation, operational excellence and sustainable growth. He spent more than 14 years at Globe Telecom in senior leadership roles. This included eight years under its Mobile Financial Services unit, GCASH, where he was instrumental in shaping business operations and corporate planning. Most recently, Alair served as Deputy General Manager at Lulu Money Philippines. Here he led the launch of the Company's e-wallet business - overseeing startup operations, product development and full-scale deployment. Commenting on his appointment, Alair said, 'It is a privilege to join Western Union at such a transformative moment for the industry. The Philippines and surrounding markets have vibrant, fast-moving financial ecosystems and I am excited to drive Western Union's next phase of innovation and progress. I look forward to working with our teams and partners to bring trusted, relevant solutions that truly support our customers as their needs evolve and grow.' Western Union has been operating in the Philippines for over three decades, connecting customers to their loved ones globally through its physical and digital channels. The Company remains committed to supporting the financial journeys of individuals, families and communities through trusted international money transfer services. About Western Union The Western Union Company (NYSE: WU) is committed to helping people around the world who aspire to build financial futures for themselves, their loved ones and their communities. Our leading cross-border, cross-currency money movement, payments and digital financial services empower consumers, businesses, financial institutions and governments—across more than 200 countries and territories and nearly 130 currencies—to connect with billions of bank accounts, millions of digital wallets and cards, and a global footprint of hundreds of thousands of retail locations. Our goal is to offer accessible financial services that help people and communities prosper. For more information, visit
Yahoo
2 hours ago
- Yahoo
Generation Mining Announces Results of Annual Meeting of Shareholders
TORONTO, June 25, 2025--(BUSINESS WIRE)--Generation Mining Limited (TSX:GENM, OTCQB: GENMF) (the "Company") announces the voting results from its annual meeting of shareholders (the "Meeting") held earlier today. The five (5) candidates nominated for election to the Company's board of directors and listed in the Company's Management Information Circular dated May 15, 2025, were each elected by a majority of the votes cast by shareholders present in person or represented by proxy at the Meeting. Each director elected will continue to hold office until the next annual meeting of Shareholders, or until a successor is elected or appointed. The voting results were as follows: Nominee Common Shares Votes For Votes Withheld Jamie Levy 90,728,970 57,252 (99.9%) (0.1%) Kerry Knoll 90,733,822 52,400 (99.9%) (0.1%) Stephen Reford 90,732,122 54,100 (99.9%) (0.1%) Phillip Walford 90,627,122 159,100 (99.8%) (0.2%) Rebecca Hudson 90,610,049 176,173 (99.8%) (0.2%) Shareholders of the Company also voted in favour of a resolution to re-appoint RSM Canada LLP as the auditor of the Company until the next annual meeting of Shareholders and the board of directors were authorized to fix the remuneration of the auditor. The full report of voting results from the Meeting is available under the Company's issuer profile on SEDAR+ at View source version on Contacts For further information please contact:Jamie LevyPresident and Chief ExecutiveOfficer(416) 640-2934 (O)(416) 567-2440 (M)jlevy@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 hours ago
- Business Wire
Generation Mining Announces Results of Annual Meeting of Shareholders
TORONTO--(BUSINESS WIRE)--Generation Mining Limited (TSX:GENM, OTCQB: GENMF) (the 'Company ') announces the voting results from its annual meeting of shareholders (the ' Meeting ') held earlier today. The five (5) candidates nominated for election to the Company's board of directors and listed in the Company's Management Information Circular dated May 15, 2025, were each elected by a majority of the votes cast by shareholders present in person or represented by proxy at the Meeting. Each director elected will continue to hold office until the next annual meeting of Shareholders, or until a successor is elected or appointed. The voting results were as follows: Shareholders of the Company also voted in favour of a resolution to re-appoint RSM Canada LLP as the auditor of the Company until the next annual meeting of Shareholders and the board of directors were authorized to fix the remuneration of the auditor. The full report of voting results from the Meeting is available under the Company's issuer profile on SEDAR+ at
